Results 1 to 10 of about 258,529 (142)
Correspondence: Acute Lymphoblastic Leukaemia and HbE-alpha Thalassaemia. [PDF]
Sir, The recent report on “Acute Lymphoblastic Leukaemia and HbE-alpha Thalassaemia” is very interesting [1]. Rajendran et al., presented a case study and mentioned that “though malignancies are one of the complications in thalassaemia, occurrence of ...
Yasri S, Wiwanitkit V.
europepmc +2 more sources
Cerebral Blood Flow Is Associated with Diagnostic Class and Cognitive Decline in Alzheimer’s Disease
Background: Reliable cerebral blood flow (CBF) biomarkers using a noninvasive imaging technique are sought to facilitate early diagnosis and intervention in early Alzheimer’s disease (AD).
Wenna Duan +9 more
semanticscholar +1 more source
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2023 Update
Background: Since 2020, annual reports on the clinical development of new drug-based therapies for the neurodegenerative condition of Parkinson’s disease (PD) have been generated. These reviews have followed the progress of both “symptomatic treatments” (
K. McFarthing +7 more
semanticscholar +1 more source
Background: Chronic obstructive pulmonary disease-associated pulmonary hypertension (PH-COPD) results in a significant impact on symptoms, quality of life, and survival. There is scant and conflicting evidence about the use of pulmonary hypertension (PH)
A. Elkhapery +8 more
semanticscholar +1 more source
Background Longitudinal changes in volumetric MRI outcome measures have been shown to correlate well with longitudinal changes in clinical instruments and have been widely used as biomarker outcomes in clinical trials for Alzheimer’s disease (AD).
M. ten Kate, F. Barkhof, Adam J. Schwarz
semanticscholar +1 more source
Structured Abstract Background Adult congenital heart disease (ACHD) is a lifelong illness that presents ongoing challenges to quality of life. Fostering personal resilience resources to sustain well-being can enhance patients’ psychosocial health ...
J. Steiner +7 more
semanticscholar +1 more source
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update
Background: As the international community dealt with the ongoing COVID-19 pandemic, important progress continued to be made in the development of new drug-based therapies for the neurodegenerative condition of Parkinson’s disease (PD) in 2021.
K. McFarthing +6 more
semanticscholar +1 more source
Background: Multiple studies have reported brain lipidomic abnormalities in Alzheimer’s disease (AD) that affect glycerophospholipids, sphingolipids, and fatty acids.
Jan Krzysztof Blusztajn +9 more
semanticscholar +1 more source
Sorting of chromosomes by magnetic separation [PDF]
Chromosomes were isolated from Chinese hamster x human hybrid cell lines containing four and nine human chromosomes. Human genomic DNA was biotinylated by nick translation and used to label the human chromosomes by in situ hybridization in suspension ...
A Oberteufer +30 more
core +1 more source
Histone deacetylase 5 (HDAC5) belongs to class II HDAC subfamily and is reported to be increased in the kidneys of diabetic patients and animals. However, little is known about its function and the exact mechanism in diabetic kidney disease (DKD).
Zhaoxia Xu +6 more
semanticscholar +1 more source

